Teli Liu

1.0k total citations
49 papers, 798 citations indexed

About

Teli Liu is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Teli Liu has authored 49 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Radiology, Nuclear Medicine and Imaging, 26 papers in Oncology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Teli Liu's work include Radiopharmaceutical Chemistry and Applications (32 papers), Peptidase Inhibition and Analysis (10 papers) and Prostate Cancer Treatment and Research (10 papers). Teli Liu is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (32 papers), Peptidase Inhibition and Analysis (10 papers) and Prostate Cancer Treatment and Research (10 papers). Teli Liu collaborates with scholars based in China, Ethiopia and United States. Teli Liu's co-authors include Hua Zhu, Zhi Yang, Nan Li, Xiaoyi Guo, Xiaoxia Xu, Lei Xia, Chen Liu, Jin Ding, Nina Zhou and Xing Yang and has published in prestigious journals such as Radiology, ACS Applied Materials & Interfaces and Small.

In The Last Decade

Teli Liu

46 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teli Liu China 17 441 348 280 123 119 49 798
Mickaël Bourgeois France 22 648 1.5× 319 0.9× 200 0.7× 75 0.6× 189 1.6× 45 996
Janneke D.M. Molkenboer‐Kuenen Netherlands 16 535 1.2× 414 1.2× 267 1.0× 117 1.0× 211 1.8× 33 956
Samantha Y.A. Terry United Kingdom 19 474 1.1× 315 0.9× 186 0.7× 60 0.5× 219 1.8× 49 851
Joseph J. Grudzinski United States 14 348 0.8× 195 0.6× 256 0.9× 329 2.7× 174 1.5× 44 924
Alexander H. Staudacher Australia 15 355 0.8× 443 1.3× 141 0.5× 75 0.6× 225 1.9× 33 780
Huiyun Zhao China 19 458 1.0× 263 0.8× 124 0.4× 151 1.2× 254 2.1× 38 894
Christine Ellingsen Norway 17 512 1.2× 217 0.6× 196 0.7× 94 0.8× 104 0.9× 32 774
Karen Wong United States 22 693 1.6× 355 1.0× 261 0.9× 124 1.0× 311 2.6× 43 1.2k
Sébastien Gouard France 18 450 1.0× 259 0.7× 178 0.6× 52 0.4× 159 1.3× 37 758
Jessie R. Nedrow United States 16 815 1.8× 497 1.4× 420 1.5× 148 1.2× 233 2.0× 37 1.3k

Countries citing papers authored by Teli Liu

Since Specialization
Citations

This map shows the geographic impact of Teli Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teli Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teli Liu more than expected).

Fields of papers citing papers by Teli Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teli Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teli Liu. The network helps show where Teli Liu may publish in the future.

Co-authorship network of co-authors of Teli Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Teli Liu. A scholar is included among the top collaborators of Teli Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teli Liu. Teli Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zilei, et al.. (2024). Construction of [89Zr]Zr-Labeled HuL13 for ImmunoPET Imaging of LAG-3 Checkpoint Expression on Tumor-Infiltrating T Cells. Molecular Pharmaceutics. 21(8). 3992–4003. 3 indexed citations
2.
Ding, Jin, Qian Zhang, Nina Zhou, et al.. (2024). Preclinical Evaluation and Pilot Clinical Study of 18F-Labeled Inhibitor Peptide for Noninvasive Positron Emission Tomography Mapping of Angiotensin Converting Enzyme 2. ACS Pharmacology & Translational Science. 7(6). 1758–1769. 2 indexed citations
3.
Zhou, Nina, et al.. (2024). Comparison of an Affibody-based Molecular Probe and 18F-FDG for Detecting HER2-Positive Breast Cancer at PET/CT. Radiology. 311(3). e232209–e232209. 10 indexed citations
4.
Zhou, Nina, Zhen Wang, Teli Liu, et al.. (2024). Construction and Application of a PD-L1-Targeted Multimodal Diagnostic and Dual-Functional Theranostics Nanoprobe. International Journal of Nanomedicine. Volume 19. 5479–5492. 4 indexed citations
5.
Yang, Nan, Xiaoyi Guo, Feng Wang, et al.. (2024). Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational. Seminars in Nuclear Medicine. 54(6). 792–800. 6 indexed citations
6.
Liu, Teli, Siming Li, Xiaokun Ma, et al.. (2023). An iodine‑labelled Antibody–drug conjugate PET probe for noninvasive monitoring of Nectin-4 expression in urothelial carcinoma. International Journal of Pharmaceutics. 651. 123756–123756. 12 indexed citations
7.
Xia, Lei, Xiangxi Meng, Teli Liu, et al.. (2023). Preparation and Application of a Bioorganic Nanoparticle-Enhanced PDL1-Targeted Small-Molecule Probe. ACS Applied Materials & Interfaces. 15(25). 30619–30629. 11 indexed citations
8.
Yao, Yuan, Jinyu Zhu, Xiaokun Ma, et al.. (2023). Construction and preclinical evaluation of a zirconium-89 labelled monoclonal antibody targeting PD-L2 in lung cancer. Biomedicine & Pharmacotherapy. 168. 115602–115602. 5 indexed citations
9.
Liu, Song, Teli Liu, Wei Tian, et al.. (2023). Unique role of molecular imaging probes for viral infection. TrAC Trends in Analytical Chemistry. 170. 117470–117470. 1 indexed citations
10.
Liu, Chen, Teli Liu, Xiaojiang Duan, et al.. (2022). Preclinical evaluation and first in human study of Al18F radiolabeled ODAP-urea-based PSMA targeting ligand for PET imaging of prostate cancer. Frontiers in Oncology. 12. 1030187–1030187. 6 indexed citations
11.
Liu, Teli, Ning Zhang, Xiaoyi Guo, et al.. (2021). 64Cu-PSMA-BCH: a new radiotracer for delayed PET imaging of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 48(13). 4508–4516. 17 indexed citations
12.
Xia, Lei, Xiangxi Meng, Nina Zhou, et al.. (2021). Application Analysis of 124I-PPMN for Enhanced Retention in Tumors of Prostate Cancer Xenograft Mice. International Journal of Nanomedicine. Volume 16. 7685–7695. 5 indexed citations
13.
Zhou, Xin, Xue Yang, Teli Liu, et al.. (2021). First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients. Journal of Nuclear Medicine. 63(4). 536–542. 99 indexed citations
14.
Liu, Chen, Teli Liu, Zhongyi Zhang, et al.. (2020). 68Ga-PSMA PET/CT Combined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose Clinically Significant Prostate Cancer in Men with Previous Negative Biopsy Results. Journal of Nuclear Medicine. 61(9). 1314–1319. 61 indexed citations
15.
Guo, Xiaoyi, Nina Zhou, Zuhua Chen, et al.. (2020). Construction of 124I-trastuzumab for noninvasive PET imaging of HER2 expression: from patient-derived xenograft models to gastric cancer patients. Gastric Cancer. 23(4). 614–626. 26 indexed citations
16.
Xu, Xiaoxia, Teli Liu, Fei Liu, et al.. (2019). Synthesis and evaluation of 64Cu-radiolabeled NOTA-cetuximab (64Cu-NOTA-C225) for immuno-PET imaging of EGFR expression. Chinese Journal of Cancer Research. 31(2). 400–409. 3 indexed citations
17.
Zhu, Hua, Fei Liu, Yan Zhang, et al.. (2019). (2S,4R)-4-[18F]Fluoroglutamine as a PET Indicator for Bone Marrow Metabolism Dysfunctional: from Animal Experiments to Clinical Application. Molecular Imaging and Biology. 21(5). 945–953. 8 indexed citations
18.
Li, Guanghui, Teli Liu, Yakun Wan, et al.. (2019). Evaluation of 64Cu radiolabeled anti-hPD-L1 Nb6 for positron emission tomography imaging in lung cancer tumor mice model. Bioorganic & Medicinal Chemistry Letters. 30(4). 126915–126915. 13 indexed citations
19.
Guo, Xiaoyi, Hua Zhu, Nina Zhou, et al.. (2018). Noninvasive Detection of HER2 Expression in Gastric Cancer by 64Cu-NOTA-Trastuzumab in PDX Mouse Model and in Patients. Molecular Pharmaceutics. 15(11). 5174–5182. 18 indexed citations
20.
Liu, Chen, Teli Liu, Ning Zhang, et al.. (2018). 68Ga-PSMA-617 PET/CT: a promising new technique for predicting risk stratification and metastatic risk of prostate cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 45(11). 1852–1861. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mickaël Bourgeois Breakdown of academic impact, for papers by Janneke D.M. Molkenboer‐Kuenen Breakdown of academic impact, for papers by Samantha Y.A. Terry Breakdown of academic impact, for papers by Joseph J. Grudzinski Breakdown of academic impact, for papers by Alexander H. Staudacher Breakdown of academic impact, for papers by Huiyun Zhao Breakdown of academic impact, for papers by Christine Ellingsen Breakdown of academic impact, for papers by Karen Wong Breakdown of academic impact, for papers by Sébastien Gouard Breakdown of academic impact, for papers by Jessie R. Nedrow
Rankless by CCL
2026